Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health ...

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Elevance Health (ELV – Research Report) yesterday and set a price target of $485.00. The company’s shares closed yesterday at ...

Elevance Health is ramping up care coordination with new members in a move the company says helps it predict and prepare for medical cost trends that have dogged the health insurance sector.

Elevance Health executives sought to ease the minds of skittish investors on Wall Street Tuesday, saying that while medical costs in Medicare Advantage remain elevated—following with an ongoing ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Peter Haytaian; Executive Vice ...

Health insurance provider Elevance Health (NYSE:EVH) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 14.5% year on year to $48.77 billion. Its non-GAAP profit of ...

The health insurer posted revenue of $48.89 billion in the period. Its adjusted revenue was $48.77 billion, also topping Street forecasts. Seventeen analysts surveyed by Zacks expected $46.03 billion.

Companies aim for a ratio close to around 80%. Bengaluru: Health insurer Elevance Health said on Tuesday its first-quarter profit came above Street expectations, matching the preliminary estimates ...